Image

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

We're studying how kids with transplants respond to respiratory viruses.

Recruiting
18 years and younger
All
Phase N/A

This study is for kids under 18 who are getting a bone marrow (hematopoietic cell) or organ transplant. Researchers want to see if checking for viruses before the transplant can predict if the child will get a respiratory (breathing-related) virus infection within a year after the transplant. They will take a nose swab and blood sample when you join the study and again 100 days after your transplant. This helps them understand how the body fights these infections.

  • The study lasts for one year after the transplant, with sample collections at the start and 100 days post-transplant.
  • Participants must be getting a transplant soon or have just had one, and must be under the care of a participating center.
  • Parents/guardians must agree to the study, and if appropriate, the child must also agree.

There are no risks listed for the recipients, but donors must be ready to give a blood sample before the transplant. This study could help future transplant patients fight off viral infections better.

Study details
    Hematopoietic Cell Transplant
    Solid Organ Transplant
    Respiratory Viral Infection

NCT05550298

Arkansas Children's Hospital Research Institute

29 March 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.